Download PDF
Geburtshilfe Frauenheilkd 2006; 66(2): 135-144
DOI: 10.1055/s-2005-872917
Übersicht

Georg Thieme Verlag KG Stuttgart · New York

Rhythmusstörungen während Schwangerschaft und Stillzeit. Häufigkeit - Diagnostik - Therapie

Arrhythmias During Pregnancy and Breastfeeding. Incidence - Diagnosis - TherapyH.-J. Trappe1
  • 1Medizinische Klinik II (Schwerpunkte Kardiologie und Angiologie), Marienhospital Herne, Ruhr-Universität Bochum
Further Information

Publication History

Eingang Manuskript: 27.6.2005 Eingang revidiertes Manuskript: 19.8.2005

Akzeptiert: 21.9.2005

Publication Date:
07 March 2006 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Supraventrikuläre Extrasystolen werden während einer Schwangerschaft (SWS) häufig beobachtet, supraventrikuläre Tachykardien (atriale Tachykardien, AV-Knoten-Reentry-Tachykardien, „circus-movement“-Tachykardien) dagegen eher seltener. Zur Akut-Therapie (AT) ist bei hämodynamischer Instabilität (HI) eine elektrische Kardioversion (KV) mit 50 - 100 Joule notwendig. Bei stabiler Hämodynamik (SH) sollten primär vagale Manöver durchgeführt werden, bei Versagen vagaler Maßnahmen ist Adenosin das Medikament der 1. Wahl. Für die Langzeit-Therapie (LZ‐T) kommen vor allem β1-selektive Betablocker (BB) infrage, seltener spezifische Antiarrhythmika (AA) der Klasse Ic oder der Klasse III (Sotalol [Sot]). Ventrikuläre Extrasystolen sind während einer SWS ebenfalls relativ häufig und bei den meisten Patientinnen (Pt) harmlos, maligne ventrikuläre Arrhythmien (ventrikuläre Tachykardien [KT], Kammerflattern [KFlat], Kammerflimmern [KF]) werden dagegen eher seltener beobachtet. Als AT sollte bei HI eine elektrische KV erfolgen, bei SH kommen Ajmalin, Procainamid oder Lidocain in Betracht. Für die LZ‐T sollten primär β1-selektive BB eingesetzt werden, bei Therapierefraktärität kommen spezifische AA der Klasse Ic oder Sot in Betracht. Für Pt mit synkopaler KT, KF, KFlat oder überlebtem plötzlichem Tod ist der implantierbare Defibrillator eine therapeutische Alternative. Bei Pt mit symptomatischen Bradykardien kann unter Echokontrolle ein Schrittmachersystem in jedem Stadium der SWS implantiert werden. Trotz notwendiger Besonderheiten im therapeutischen Verhalten während einer SWS können alle supraventrikulären und/oder ventrikulären Arrhythmien adäquat behandelt und bei sorgfältiger Beachtung von Risiken, Nebenwirkungen und Komplikationen aller therapeutischen Maßnahmen können auch komplizierte Schwangerschaften erfolgreich beendet werden. Auch in der Stillzeit können zahlreiche Antiarrhythmika ohne Probleme angewendet werden.

Abstract

Atrial premature beats are frequently diagnosed during pregnancy (PR), supraventricular tachycardia (SVT)(atrial tachycardia, AV nodal reentrant tachycardia, circus movement tachycardia) less frequently. For acute therapy, electrical cardioversion with 50 - 100 Joules is indicated in all unstable patients (pts). In stable SVT the initial therapy includes vagal maneuvers to terminate breakthrough tachycardias. For short-term management, when vagal maneuvers fail, intravenous adenosine is the first choice drug and may safely terminate the arrhythmia. For long-term therapy, β-blocking agents with β1 selectivity are first-line drugs; class Ic agents or the class III drug sotalol (sot) are effective and therapeutic alternatives. Ventricular premature beats are also frequently present during PR and benign in most of the pts; however, malignant ventricular tachyarrhythmias (sustained ventricular tachycardia [VT], ventricular flutter [VFlut], ventricular fibrillation [VF]) were observed less frequently. Electrical cardioversion is necessary in all pts with hemodynamically unstable situation and life-threatening ventricular tachyarrhythmias; in hemodynamically stable pts, initial therapy with ajmaline, procainamide or lidocaine is indicated. If prophylactic therapy is needed, β-blocking agents with β1 selectivity are considered as first choice drugs. If this therapy is ineffective, class Ic agents or sot can be considered. In pts with syncopal VT, VF, VFlut or aborted sudden death an implantable cardioverter-defibrillator is indicated. In pts with symptomatic bradycardia, a pacemaker can be implanted using echocardiography at any stage of PR. The treatment of of the pregnant patient with cardiac arrhythmias requires an important modification of the standard practice of arrhythmia management. The goal of therapy is to protect the patient and fetus through delivery, after which chronic or definitive therapy can be administered. In addition, antiarrhythmic therapy is also possible during breastfeeding.

Schlüsselwörter

Herzrhythmusstörungen - Schwangerschaft - Stillzeit - plötzlicher Tod - automatischer Defibrillator - Antiarrhythmika

Key words

Cardiac arrhythmias - pregnancy - breastfeeding - sudden death - automatic implantable cardioverter defibrillator - antiarrhythmic drugs

Literatur

  • 1 American Academy of Pediatrics . The transfer of drugs and other chemicals into human breast milk.  Pediatrics. 1994;  93 137-150
    PubMedGoogle Scholar
  • 2 Boesmann-Finkelstein M, Finkelstein R A. Antimicrobial effects of human milk inhibitory activity on enteric pathogens.  FEMS Microbiology Letters. 1985;  27 167-174
    CrossrefPubMedGoogle Scholar
  • 3 Bravermann A C, Bromley B S, Rutherford J D. New onset ventricular tachycardia during pregnancy.  Int J Cardiol. 1991;  33 409-412
    CrossrefPubMedGoogle Scholar
  • 4 Brodsky M, Doria R, Allen B, Sato D, Thomas G, Sada M. New-onset ventricular tachycardia during pregnancy.  Am Heart J. 1992;  123 933-941
    CrossrefPubMedGoogle Scholar
  • 5 Cardosi R J, Chez R A. Magnesium sulfate, maternal hypothermia, and fetal bradycardia with loss of heart rate variability.  Obstet Gynecol. 1998;  92 691-693
    CrossrefPubMedGoogle Scholar
  • 6 Chow T, Galvin J, McGowern B. Antiarrhythmic drug therapy in pregnancy and lactation.  Am J Cardiol. 1998;  82 58I-62I
    CrossrefPubMedGoogle Scholar
  • 7 Cleary-Goldmann J, Salva C R, Infeld J I, Robinson J N. Verapamil-sensitive idiopathic left ventricular tachycardia in pregnancy.  J Matern Fetal Neonatal Med. 2003;  14 132-135
    PubMedGoogle Scholar
  • 8 Dalvi B V, Chaudhuri A, Kulkarni H L, Purushottam K A. Therapeutic guidelines for congenital heart block presenting in pregnancy.  Obstet Gynecol. 1992;  79 802-804
    PubMedGoogle Scholar
  • 9 Danielsson B R, Azarbayjani F, Skold A C, Webster W S. Initiation of phenytoin teratogenesis: pharmacologically induced embryonic bradycardia and arrhythmia resulting in hypoxia and possible free radical damage at reoxygenation.  Teratology. 1997;  56 271-281
    CrossrefPubMedGoogle Scholar
  • 10 Davies G AL, Herbert W NP. Cardiac disease in pregnancy.  Cardiol Rev. 1995;  35 262-272
    PubMedGoogle Scholar
  • 11 Dominguez A, Iturralde P, Hermosillo A G, Colin L, Kershenovich S, Garrido L M. Successful radiofrequency ablation of an accessory pathway during pregnancy.  Pacing Clin Electrophysiol. 1999;  22 131-134
    PubMedGoogle Scholar
  • 12 Facchini M, Bauersfeld U, Fasnacht M, Candinas R. Mütterliche Herzrhythmusstörungen während der Schwangerschaft.  Schweiz Med Wochenschr. 2000;  130 1962-1969
    PubMedGoogle Scholar
  • 13 Ferrero S, Colombo B M, Ragni N. Maternal arrhythmias during pregnancy.  Arch Gynecol Obstet. 2004;  269 244-253
    PubMedGoogle Scholar
  • 14 Finlay A Y, Edmunds V. DC cardioversion in pregnancy.  Br J Clin Pract. 1979;  33 88-94
    PubMedGoogle Scholar
  • 15 Gowda R M, Khan I A, Mehta N J, Vasavada B C, Sacchi T J. Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations.  Int J Cardiol. 2003;  88 129-133
    CrossrefPubMedGoogle Scholar
  • 16 Gras D, Mabo P, Kermarrec A, Bazin P, Varin C, Daubert C. Radiofrequency ablation of atrioventricular conduction during the 5th month of pregnancy.  Arch Mal Coeur Vaiss. 1992;  85 1873-1877
    PubMedGoogle Scholar
  • 17 Gregg N M. Congenital cataract following German measles in mother.  Trans Ophthalmol Soc Aust. 1941;  3 35-46
    PubMedGoogle Scholar
  • 18 Habib A, McCarthy J S. Effects on the neonate of propranolol administered during pregnancy.  J Pediatr. 1977;  91 808-811
    PubMedGoogle Scholar
  • 19 Hohnloser S H, Meinertz T, Zehender M, Geibel A, Just H. Auslösung und Verstärkung von Herzrhythmusstörungen durch Antiarrhythmika.  Internist. 1988;  29 338-344
    PubMedGoogle Scholar
  • 20 Huang H, Lin Q, Zhang L. Clinical observation of cardiac pacemaker in pregnant women.  Chuang Hua Fu Chan Ko Tsa Chih. 1997;  32 345-346
    PubMedGoogle Scholar
  • 21 Isaacs J D, Mulholland D H, Hess L W, Albert J R, Martin R W. Pregnancy in a woman with an automatic implantable cardioverter defibrillator: a case report.  J Reprod Med. 1993;  36 487-488
    PubMedGoogle Scholar
  • 22 Joglar J A, Page R L. Treatment of cardiac arrhythmias during pregnancy: safety considerations.  Drug Saf. 1999;  20 85-94
    PubMedGoogle Scholar
  • 23 Klein H H, Pich S. Physiologische Änderungen des Herz-Kreislauf-Systems in der Schwangerschaft.  Herz. 2003;  28 173-174
    CrossrefPubMedGoogle Scholar
  • 24 Lau C P, Lee C P, Wong C K, Cheng C H, Leung W H. Rate responsive pacing with a minute ventilation sensing pacemaker during pregnancy and delivery.  Pacing Clin Electrophysiol. 1990;  13 158-163
    PubMedGoogle Scholar
  • 25 Lawrence R, Lawrence M. Breastfeeding: a guide for the medical profession. 5th edn. St. Louis; Mosby 1999
    Google Scholar
  • 26 Lee S H, Chen S A, Wu T J, Chiang C E, Cheng C C, Tai C T, Chiou C W, Ueng K C, Chang M S. Effects of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia.  Am J Cardiol. 1995;  76 675-678
    CrossrefPubMedGoogle Scholar
  • 27 Lenz W. Kindliche Fehlbildungen nach Medikament während der Gravidität?.  Dtsch Med WSchr. 1961;  86 2555-2556
    PubMedGoogle Scholar
  • 28 Magee L A, Downar E, Sermer M, Boulton B C, Allen L C, Koren G. Pregnancy outcome after gestational exposure to amiodarone in Canada.  Am J Obstet Gynecol. 1995;  172 1307-1311
    CrossrefPubMedGoogle Scholar
  • 29 McAnulty J H, Morton M J, Ueland K. The heart and pregnancy.  Curr Probl Cardiol. 1988;  13 589-665
    PubMedGoogle Scholar
  • 30 McBride W G. Thalidomide and congenital abnormalities.  Lancet. 1961;  28 1358-1364
    PubMedGoogle Scholar
  • 31 Mitani G M, Steinberg I, Lien E J, Harrison E C, Elkayam U. The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.  Clin Pharmacokinet. 1987;  12 253-291
    PubMedGoogle Scholar
  • 32 Mozo de Rosales F, Moreno J, Bodegas A, Melchor J C, Fernandez Lebrez L, Aranguren G. Conversion of atrial fibrillation with ajmaline in a pregnant woman with Wolff-Parkinson-White syndrome.  Eur J Obstet Gynecol. 1994;  56 63-66
    CrossrefPubMedGoogle Scholar
  • 33 Nakagawa M, Katou S, Ichinose M, Nobe S, Yonemochi H, Miyakawa I, Saikawa T. Characteristics of new-onset ventricular arrhythmias in pregnancy.  J Electrocardiol. 2004;  37 47-53
    PubMedGoogle Scholar
  • 34 Natale A, Davidson T, Geiger M J, Newby K. Implantable cardioverter-defibrillators and pregnancy. A safe combination?.  Circulation. 1997;  96 2808-2812
    CrossrefPubMedGoogle Scholar
  • 35 Navarro V, Nathan P E, Rosero H, Sacchi T J. Accelerated idioventricular rhythm in pregnancy: a case report.  Angiology. 1993;  44 506-508
    PubMedGoogle Scholar
  • 36 Pagdad S V, Barmade A B, Toal S C, Vora A M, Lokhandwala Y Y. “Rescue” radiofrequency ablation for atrial tachycardia presenting as cardiomyopathy in pregnancy.  Indian Heart J. 2004;  56 245-247
    PubMedGoogle Scholar
  • 37 Page R L. Treatment of arrhythmias during pregnancy.  Am Heart J. 1995;  130 871-876
    CrossrefPubMedGoogle Scholar
  • 38 Page R L, Shenasa H, Evans J, Sorrentino R A, Wharton J M, Prystowsky E N. Radiofrequency catheter ablation of idiopathic recurrent ventricular tachycardia with a right bundle branch block, left axis pattern.  Pace Clin Electrophysiol. 1993;  16 327-336
    PubMedGoogle Scholar
  • 39 Piper J M, Berkus M, Ridgway L E. Pregnancy complicated by chronic cardiomyopathy and an automatic implantable cardioverter defibrillator.  Am J Obstet Gynecol. 1992;  167 506-507
    PubMedGoogle Scholar
  • 40 Plomp T A, Vulsma T, de Vijlder J J. Use of amiodarone during pregnancy.  Eur J Obstet Gynecol Reprod Biol. 1992;  43 201-207
    PubMedGoogle Scholar
  • 41 Rahilly G T, Prystowsky E N, Zipes D P, Nacarelli G V, Jackman W M, Heger J J. Clinical and electrophysiologic findings in patients with repetitive monomorphic ventricular tachycardia and otherwise normal electrocardiogram.  Am J Cardiol. 1982;  50 459-468
    CrossrefPubMedGoogle Scholar
  • 42 Ramsewak S, Persad P, Perkins S, Narayansingh G. Twin pregnancy in a patient with complete heart block. A case report.  Clin Exp Obstet Gynecol. 1992;  19 166-167
    PubMedGoogle Scholar
  • 43 Rotmensch H H, Elkayam U, Frishman W. Antiarrhythmic drug therapy during pregnancy.  Ann Intern Med. 1983;  98 487-497
    PubMedGoogle Scholar
  • 44 Saarinen U M, Patwari A K, Satyanarayana L. Relactation: an effective intervention to promote exclusive breastfeeding.  J Trop Pediatrics. 1997;  43 213-216
    PubMedGoogle Scholar
  • 45 Schaefer C, Spielmann H. Arzneiverordnung in Schwangerschaft und Stillzeit. München, Jena; Urban & Fischer 2001: 2-26
    Google Scholar
  • 46 Schaefer C, Spielmann H. Spezielle Arzneimitteltherapie in der Stillzeit. Schaefer C, Spielmann Arzneiverordnung in Schwangerschaft und Stillzeit. München-Jena; Urban & Fische 2001: 440-599
    Google Scholar
  • 47 Schardein J L. Chemically Induced Birth Defects. 4th edn. New York; Marcel Dekker 2000
    Google Scholar
  • 48 Sermer M, Colman J, Siu S. Pregnancy complicated by heart disease: a review of Canadian experience.  J Obstet Gynaecol. 2003;  23 540-544
    CrossrefPubMedGoogle Scholar
  • 49 Shotan A, Ostrzega E, Mehra A, Johnson J V, Elkayam U. Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope.  Am J Cardiol. 1997;  79 1061-1064
    CrossrefPubMedGoogle Scholar
  • 50 Oakley C, Child A, Lung B. Task Force Members . Expert consensus document on management of cardiovascular diseases during pregnancy.  Eur Heart J. 2003;  24 761-781
    CrossrefPubMedGoogle Scholar
  • 51 Trappe H J, Pfitzner P, Fieguth H G, Wenzlaff P, Kielblock B, Klein H. Nonpharmacological therapy of ventricular tachyarrhythmias: observations in 554 patients.  Pace. 1994;  17 2172-2177
    PubMedGoogle Scholar
  • 52 Trappe H J. Therapie von Herzrhythmusstörungen ohne Antiarrhythmika. Möglichkeiten und Indikationen. Gerok W, Hartmann F, Pfreundschuh M, Philipp T, Schuster HP, Sybrecht GW Klinik der Gegenwart. München; Urban & Schwarzenberg 1996: 14: 1-25
    Google Scholar
  • 53 Trappe H J. Akuttherapie supraventrikulärer Tachykardien: Adenosin oder Ajmalin?.  Intensivmed. 1997;  34 452-461
    CrossrefPubMedGoogle Scholar
  • 54 Trappe H J, Schuster H P. Brugada-Syndrom. Definition, Diagnostik, Therapie, Prognose.  Intensivmed. 2000;  37 680-687
    CrossrefPubMedGoogle Scholar
  • 55 Trappe H J. Amiodaron.  Intensivmed. 2001;  38 169-178
    CrossrefPubMedGoogle Scholar
  • 56 Varon M E, Sherer D M, Abramowicz J S, Akiyama T. Maternal ventricular tachycardia associated with hypomagnesemia.  Am J Obstet Gynecol. 1992;  167 1352-1355
    PubMedGoogle Scholar
  • 57 Vaughan Williams E M. A classification of antiarrhythmic actions reassessed after a decade of new drugs.  J Clin Pharmacol. 1984;  24 129-147
    PubMedGoogle Scholar
  • 58 Wada H, Chiba Y, Murakami M, Kawaguchi H, Kobayashi H, Kanzaki T. Analysis of maternal and fetal risk in 594 pregnancies with heart disease.  Nippon Sanka Fujinka Gakkai Zasshi. 1996;  48 255-262
    PubMedGoogle Scholar
  • 59 Walsh K A, Erzi M D, Denes P. Emergency treatment of tachyarrhythmias.  Med Clin North Am. 1988;  70 791-811
    PubMedGoogle Scholar
  • 60 Warkany J, Nelson R C. Appearance of skeletal abnormalities in the offspring of rats retarded on a deficient diet.  Science. 1940;  92 383-384
    PubMedGoogle Scholar
  • 61 Wellens H JJ, Conover M B. The ECG in emergency decision making. 2nd ed. Philadelphia, New York; WB Saunders Company 2006
    Google Scholar
  • 62 Widerhorn J, Widerhorn A LM, Rahimtoola S H, Elkayam U. WPW syndrome during pregnancy: increased incidence of supraventricular arrhythmias.  Am Heart J. 1992;  123 796-798
    CrossrefPubMedGoogle Scholar
  • 63 Wilson J D. Embryotoxicity of drugs to man. Wilson JD, Frazer FC Handbook of teratology. New York; Plenum Press 1977: 309-355
    Google Scholar
  • 64 Wolbrette D. Treatment of arrhythmias during pregnancy.  Curr Womens Health Rep. 2003;  3 135-139
    PubMedGoogle Scholar

Univ.-Prof. Dr. med. Hans-Joachim Trappe

Medizinische Klinik II (Schwerpunkte Kardiologie und Angiologie)
Ruhr-Universität Bochum

Hölkeskampring 40

44625 Herne

Email: Hans-Joachim.Trappe@ruhr-uni-bochum.de

      >